These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14005656)

  • 1. Treatment of endotoxic shock--the dilemma of vasopressor and vasodilator therapy.
    WEIL MH; SUDRANN RB; SHUBIN H
    Calif Med; 1962 Feb; 96(2):86-8. PubMed ID: 14005656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on experimental shock: production of ischemic necrosis of the skin by an intradermal injection of endotoxin or vasopressor amine.
    EVERS CG; BRUNSON JG
    Am J Pathol; 1960 Nov; 37(5):551-67. PubMed ID: 13697652
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasopressor and vasodilator drugs in the treatment of shock.
    Bradley EC; Weil MH
    Mod Treat; 1967 Mar; 4(2):243-55. PubMed ID: 5592030
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of vasopressin, norepinephrine, and L-arginine on intestinal microcirculation in endotoxemia.
    Nakajima Y; Baudry N; Duranteau J; Vicaut E
    Crit Care Med; 2006 Jun; 34(6):1752-7. PubMed ID: 16625119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin releases a substance from the aorta that dilates an isolated arteriole by up-regulating INOS.
    Viol AW; Prewitt RL; Doviak M; Britt LD
    J Surg Res; 2005 Aug; 127(2):106-11. PubMed ID: 15921695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of vasopressor and vasodilator on hemodynamic energy in terms of surplus hemodynamic energy.
    Lim CH; Yang S; Son HS; Lee JJ; Yoon JR; Lee SH; Lee HW; Sun K
    ASAIO J; 2008; 54(5):534-7. PubMed ID: 18812748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock.
    Sennoun N; Montemont C; Gibot S; Lacolley P; Levy B
    Crit Care Med; 2007 Jul; 35(7):1736-40. PubMed ID: 17522580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin for the management of catecholamine-resistant anaphylactic shock.
    Hussain AM; Yousuf B; Khan MA; Khan FH; Khan FA
    Singapore Med J; 2008 Sep; 49(9):e225-8. PubMed ID: 18830525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock.
    Martikainen TJ; Uusaro A; Tenhunen JJ; Ruokonen E
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):935-43. PubMed ID: 15315609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock.
    Pullamsetti SS; Maring D; Ghofrani HA; Mayer K; Weissmann N; Rosengarten B; Lehner M; Schudt C; Boer R; Grimminger F; Seeger W; Schermuly RT
    Thromb Haemost; 2006 Apr; 95(4):720-7. PubMed ID: 16601845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release and hemodynamic influence of nitro-glycerine-derived nitric oxide in endotoxemic rats.
    Kozlov AV; Albrecht M; Donnelly EM; Jafarmadar M; Szelenyi Z; Nohl H; Redl H; Bahrami S
    Vascul Pharmacol; 2005 Dec; 43(6):411-4. PubMed ID: 16183331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NO donor SIN-1 improves intestinal-arterial P(CO(2)) gap in experimental endotoxemia: an animal study.
    Siegemund M; Van Bommel J; Sinaasappel M; Schwarte LA; Studer W; Girard T; Vollebregt K; Ince C
    Acta Anaesthesiol Scand; 2007 Jul; 51(6):693-700. PubMed ID: 17567269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin: vasopressin analog and novel drug for septic shock.
    Pesaturo AB; Jennings HR; Voils SA
    Ann Pharmacother; 2006 Dec; 40(12):2170-7. PubMed ID: 17148649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in forearm vascular reactivity in patients with septic shock.
    Kienbaum P; Prante C; Lehmann N; Sander A; Jalowy A; Peters J
    Anaesthesia; 2008 Feb; 63(2):121-8. PubMed ID: 18211441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia.
    Ertmer C; Bone HG; Morelli A; Van Aken H; Erren M; Lange M; Traber DL; Westphal M
    Shock; 2007 Mar; 27(3):281-8. PubMed ID: 17304109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal steroids, infection and endotoxin shock.
    PLIMPTON CH
    J Med Assoc State Ala; 1961 Mar; 30():464-8. PubMed ID: 13736358
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional and structural adaptations of coronary microvessels distal to a chronic coronary artery stenosis.
    Sorop O; Merkus D; de Beer VJ; Houweling B; Pistea A; McFalls EO; Boomsma F; van Beusekom HM; van der Giessen WJ; VanBavel E; Duncker DJ
    Circ Res; 2008 Apr; 102(7):795-803. PubMed ID: 18292598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin and terlipressin: pharmacology and its clinical relevance.
    Kam PC; Williams S; Yoong FF
    Anaesthesia; 2004 Oct; 59(10):993-1001. PubMed ID: 15488059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.